Kyle Griffin @kylegriffin1
After reviewing new information from large clinical trials the agency now believes that the suggested dosing regimens "are unlikely to produce an antiviral effect," FDA chief scientist Denise Hinton said in a letter announcing the decision. — PolitiTweet.org
Kyle Griffin @kylegriffin1
Breaking via Politico: The FDA has withdrawn emergency use authorizations for hydroxychloroquine and chloroquine —… https://t.co/vL8QaaWUSO